These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32939009)

  • 1. A membrane transporter determines the spectrum of activity of a potent platinum-acridine hybrid anticancer agent.
    Yao X; Watkins NH; Brown-Harding H; Bierbach U
    Sci Rep; 2020 Sep; 10(1):15201. PubMed ID: 32939009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a Platinum-Acridine Anticancer Agent and Its Liposomal Formulation in an in vivo Model of Lung Adenocarcinoma.
    Ding S; Hackett CL; Liu F; Hackett RG; Bierbach U
    ChemMedChem; 2021 Jan; 16(2):412-419. PubMed ID: 32975041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EZH2i EPZ-6438 and HDACi vorinostat synergize with ONC201/TIC10 to activate integrated stress response, DR5, reduce H3K27 methylation, ClpX and promote apoptosis of multiple tumor types including DIPG.
    Zhang Y; Zhou L; Safran H; Borsuk R; Lulla R; Tapinos N; Seyhan AA; El-Deiry WS
    Neoplasia; 2021 Aug; 23(8):792-810. PubMed ID: 34246076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine-Directed Bioconjugation of a Platinum(II)-Acridine Anticancer Agent.
    Yao X; Tracy CM; Bierbach U
    Inorg Chem; 2019 Jan; 58(1):43-46. PubMed ID: 30543413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer.
    Ma Z; Choudhury JR; Wright MW; Day CS; Saluta G; Kucera GL; Bierbach U
    J Med Chem; 2008 Dec; 51(23):7574-80. PubMed ID: 19012390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative chemogenomics to examine the mechanism of action of dna-targeted platinum-acridine anticancer agents.
    Cheung-Ong K; Song KT; Ma Z; Shabtai D; Lee AY; Gallo D; Heisler LE; Brown GW; Bierbach U; Giaever G; Nislow C
    ACS Chem Biol; 2012 Nov; 7(11):1892-901. PubMed ID: 22928710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redesigning the DNA-targeted chromophore in platinum-acridine anticancer agents: a structure-activity relationship study.
    Pickard AJ; Liu F; Bartenstein TF; Haines LG; Levine KE; Kucera GL; Bierbach U
    Chemistry; 2014 Dec; 20(49):16174-87. PubMed ID: 25302716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a Chiral DNA-Targeted Platinum-Acridine Agent with Potent Enantioselective Anticancer Activity.
    Zhang S; Yao X; Watkins NH; Rose PK; Caruso SR; Day CS; Bierbach U
    Angew Chem Int Ed Engl; 2020 Dec; 59(49):21965-21970. PubMed ID: 32835419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
    Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the DNA damage produced by a platinum-acridine antitumor agent and its effects in NCI-H460 lung cancer cells.
    Qiao X; Zeitany AE; Wright MW; Essader AS; Levine KE; Kucera GL; Bierbach U
    Metallomics; 2012 Jul; 4(7):645-52. PubMed ID: 22456976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).
    Burger H; Zoumaro-Djayoon A; Boersma AW; Helleman J; Berns EM; Mathijssen RH; Loos WJ; Wiemer EA
    Br J Pharmacol; 2010 Feb; 159(4):898-908. PubMed ID: 20067471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PT-ACRAMTU, a platinum-acridine anticancer agent, lengthens and aggregates, but does not stiffen or soften DNA.
    Dutta S; Snyder MJ; Rosile D; Binz KL; Roll EH; Suryadi J; Bierbach U; Guthold M
    Cell Biochem Biophys; 2013; 67(3):1103-13. PubMed ID: 23636685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function.
    Chen Y; Teranishi K; Li S; Yee SW; Hesselson S; Stryke D; Johns SJ; Ferrin TE; Kwok P; Giacomini KM
    Pharmacogenomics J; 2009 Apr; 9(2):127-36. PubMed ID: 19172157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).
    Yonezawa A; Masuda S; Yokoo S; Katsura T; Inui K
    J Pharmacol Exp Ther; 2006 Nov; 319(2):879-86. PubMed ID: 16914559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum-Acridine Anticancer Agent.
    Zheng Y; Fahrenholtz CD; Hackett CL; Ding S; Day CS; Dhall R; Marrs GS; Gross MD; Singh R; Bierbach U
    Chemistry; 2017 Mar; 23(14):3386-3397. PubMed ID: 28122141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-crosslinking platinum-acridine hybrid agent shows enhanced cytotoxicity compared to clinical BCNU and cisplatin in glioblastoma cells.
    Hess SM; Anderson JG; Bierbach U
    Bioorg Med Chem Lett; 2005 Jan; 15(2):443-6. PubMed ID: 15603970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A folate-conjugated platinum porphyrin complex as a new cancer-targeting photosensitizer for photodynamic therapy.
    Yang M; Deng J; Guo D; Zhang J; Yang L; Wu F
    Org Biomol Chem; 2019 May; 17(21):5367-5374. PubMed ID: 31106316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting RNA polymerase I transcription machinery in cancer cells by a novel monofunctional platinum-based agent.
    Zhang ZL; Zhao CL; Chen Q; Xu K; Qiao X; Xu JY
    Eur J Med Chem; 2018 Jul; 155():434-444. PubMed ID: 29908438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells.
    Tsuda M; Terada T; Ueba M; Sato T; Masuda S; Katsura T; Inui K
    J Pharmacol Exp Ther; 2009 Apr; 329(1):185-91. PubMed ID: 19164462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of Copper Trafficking Proteins with the Platinum Anticancer Drug Kiteplatin.
    Barbanente A; Galliani A; Iacobazzi RM; Lasorsa A; Nardella MI; Pennetta A; Margiotta N; Arnesano F
    ChemMedChem; 2022 Jan; 17(1):e202100593. PubMed ID: 34727402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.